Clinical trial
Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric…
NCT00043979 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00043979 |
|---|---|
| Title | Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas |
| Official title | Pilot Study of Allogeneic/Syngeneic Blood Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | F-18 Fluorodeoxyglucose, therapeutic allogeneic lymphocytes, cyclophosphamide, cyclosporine, doxorubicin hydrochloride, etoposide, fludarabine phosphate, melphalan, prednisone, sirolimus and 5 more |
| Enrollment | 60 |
| Start date | Sep 19, 2002 |
| Primary completion | May 1, 2009 |
| Completion | Dec 14, 2011 |
| First posted | Aug 16, 2002 |
| Last update posted | May 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: